| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/30/2009 | WO2004092199A3 Method for identifying modulators of g protein coupled receptor signaling |
| 04/30/2009 | US20090113573 Modification of Flavonoid Biosynthesis in Plants |
| 04/30/2009 | US20090113571 Root-specific phosphate transporter promoters |
| 04/30/2009 | US20090113570 Plants with altered root architecture, related constructs and methods involving genes encoding exostosin family polypeptides and homologs thereof |
| 04/30/2009 | US20090113569 Root-specific phosphate transporter promoters |
| 04/30/2009 | US20090113565 Methods for Detecting Fluorescent Proteins and Animals Having Fluorescent Proteins |
| 04/30/2009 | US20090113564 Genetically Engineered and Phenotyped Mice and Stem Cell Clones for Producing the Same |
| 04/30/2009 | US20090113563 Probe for detecting nuclear receptor agonist or antagonist and method for screening agonist or antagonist to nuclear receptor with the use of the same |
| 04/30/2009 | US20090113562 Novel T7 Phage Peptide Display System and Uses Thereof |
| 04/30/2009 | US20090113561 Gene trap cassettes for random and targeted conditional gene inactivation |
| 04/30/2009 | US20090112479 Pathway display method, information processing device, and pathway display program product |
| 04/30/2009 | US20090111977 Antisense compound for inducing immunological tolerance |
| 04/30/2009 | US20090111973 Monolconal antibody specific to single immunoglobulin and toll-interleukin-1 receptor domain (SIGIRR) for treatment of rheumatoid arthritis, osteoporosis and inflammatory bowel diseases |
| 04/30/2009 | US20090111972 Novel hemopoietin receptor protein, nr12 |
| 04/30/2009 | US20090111767 Modulation of insulin like growth factor i receptor expression |
| 04/30/2009 | US20090111766 Raav vector-based compositions and methods for the prevention and treatment of mammalian diseases |
| 04/30/2009 | US20090111765 Compositions and methods for immunostimulatory rna oligonucleotides |
| 04/30/2009 | US20090111745 Plad Domain Peptides With Increased Serum Half Life Due To Conjugation To Domain Antibodies |
| 04/30/2009 | US20090111744 Human Growth Gene and Short Stature Gene Region |
| 04/30/2009 | US20090111706 Selection of dna adaptor orientation by amplification |
| 04/30/2009 | US20090111705 Selection of dna adaptor orientation by hybrid capture |
| 04/30/2009 | US20090111188 Optimized non-canonical zinc finger proteins |
| 04/30/2009 | US20090111187 Moss Expressing Promotion Regions |
| 04/30/2009 | US20090111186 regulatory nucleotide sequence for obtaining a transformed plants and seeds; increase in yield, disease resistance, insect resistance, herbicide tolerance, drought tolerance and salt tolerance in plants |
| 04/30/2009 | US20090111185 Female genome selection |
| 04/30/2009 | US20090111184 Chromosome selection |
| 04/30/2009 | US20090111183 Ketone Ligands for Modulating the Expression of Exogenous Genes Via An Ecdysone Receptor Complex |
| 04/30/2009 | US20090111178 Gene reporter assay, kit, and cells for determining the presence and/or the level of a molecule that activates signal transduction activity of a cell surface protein |
| 04/30/2009 | US20090111176 Trehalose transporter gene and method of introducing trehalose into cells |
| 04/30/2009 | US20090111175 Bioactive ribonucleases for treating tumors in humans |
| 04/30/2009 | US20090111170 Nucleic acid processing methods, kits and devices |
| 04/30/2009 | US20090111161 Isolated protein comprising a serine protease consisting of an amino acid sequence that is at least 95% identical to the Streptomyces 1AG3 protease; cleaning composition containing aforementioned protein |
| 04/30/2009 | US20090111160 fusion protein has trypsin and/or chymotrypsin loop being replaced with a vascular endothelial growth factor binding peptide; a culture product; anticarcinogenic agents, antitumor agents; antiinflammatory agent for treating cartilage and bone disorder; treating dermatitis |
| 04/30/2009 | US20090111159 Kits and processes for removing contaminants from nucleic acids in environmental and biological samples |
| 04/30/2009 | US20090111157 Protein and peptide fragments from mouse telomerase reverse transcriptase |
| 04/30/2009 | US20090111155 Modified xylanase exhibiting improved expression |
| 04/30/2009 | US20090111154 Butanol production by recombinant microorganisms |
| 04/30/2009 | US20090111153 Method for acyltransferase reaction using acyl coenzyme a |
| 04/30/2009 | US20090111151 Production of Polyketides |
| 04/30/2009 | US20090111146 Antibody Drug |
| 04/30/2009 | US20090111145 Production of hetero-oligomeric proteins in plants |
| 04/30/2009 | US20090111144 Transactivation system for mammalian cells |
| 04/30/2009 | US20090111142 Method for manufacturing a recombinant polyclonal protein |
| 04/30/2009 | US20090111126 Mammalian cell-based immunoglobulin display libraries |
| 04/30/2009 | US20090111123 Compositions for detecting antibodies to babesia microti and methods of uses thereof |
| 04/30/2009 | US20090111114 Rna extraction method, rna extraction reagent, and method for analyzing biological materials |
| 04/30/2009 | US20090111113 Solid support having electrostatic layer and use thereof |
| 04/30/2009 | US20090111112 Nucleic Acid Marker Ladder for Estimating Mass |
| 04/30/2009 | US20090111106 Vector System |
| 04/30/2009 | US20090111105 Androgen-dependent 1-f-aromatase reporter gene |
| 04/30/2009 | US20090111099 Promoter Detection and Analysis |
| 04/30/2009 | US20090111098 Reporter gene assay |
| 04/30/2009 | US20090110770 Galactosidase With Alpha-Galactosyltransferase Activity |
| 04/30/2009 | US20090110694 Anti-Inflammatory Proteins and Improved Vaccines |
| 04/30/2009 | US20090110690 Hiv Gp120 Crystal Structure and Its Use to Identify Immunogens |
| 04/30/2009 | US20090110687 Compositions and methods related to tim 3, a th1-specific cell surface molecule |
| 04/30/2009 | US20090110686 Antibodies against CCR5 and uses thereof |
| 04/30/2009 | US20090110684 Neutralizing monoclonal antibodies to respiratory syncytial virus |
| 04/30/2009 | US20090110682 Antibody Having Inhibitory Effect on Amyloid Fibril Formation |
| 04/30/2009 | US20090110678 Receptor antagonists for treatment of metastatic bone cancer |
| 04/30/2009 | US20090110676 BAFF, Inhibitors Thereof and Their Use in the Modulation of B-Cell Response and Treatment of Autoimmune Disorders |
| 04/30/2009 | US20090110666 Long pentraxin ptx3 functional derivatives for preparing an autologous vaccine for the treatment of tumours |
| 04/30/2009 | US20090110665 Reovirus for the treatment of neoplasia |
| 04/30/2009 | US20090110659 Immunoglobulin specific to eotaxin for use in diagnosis, prevention and treatment of infections, autoimmune, inflammatory and allergic disorders; chemotactic cytokines designated human eotaxins; selectively modulate leukocyte function |
| 04/30/2009 | US20090110643 Method of Producing Liposomes Containing Gas Enclosed Therein |
| 04/30/2009 | US20090110632 Biological materials and uses thereof |
| 04/30/2009 | DE102007053992A1 Spektral verbesserte und stickstoffautotrophe Photosynthese Spectrally enhanced photosynthesis and stickstoffautotrophe |
| 04/30/2009 | DE102007051092A1 Subtilisin aus Becillus pumilus und Wasch- und Reinigungsmittel enthaltend dieses neue Subtilisin Subtilisin from Becillus pumilus and detergents and cleaning products containing this new subtilisin |
| 04/30/2009 | CA2704051A1 Polynucleotides and methods for the improvement of plants |
| 04/30/2009 | CA2703931A1 Methods and compositions for inhibition of immune responses and autoimmunity |
| 04/30/2009 | CA2703787A1 Antibody directed against pro-gastrin releasing peptide, and use thereof |
| 04/30/2009 | CA2703774A1 Constructs containing multiple expression cassettes for cancer therapy |
| 04/30/2009 | CA2703736A1 Genetic incorporation of 3-aminotyrosine into reductases |
| 04/30/2009 | CA2703667A1 Anti-rsv g protein antibodies |
| 04/30/2009 | CA2703493A1 A cell for use in production of heteroproteins and production method using the same |
| 04/30/2009 | CA2703490A1 Regulatory elements associated with cbf transcription factor of rye |
| 04/30/2009 | CA2703482A1 Compositions and methods for delivery of glycopeptide antibiotics to medical device surfaces |
| 04/30/2009 | CA2703356A1 Method for detection of cancer |
| 04/30/2009 | CA2703191A1 Methods for the production of n-butanol |
| 04/30/2009 | CA2703140A1 Antibodies against a cancer-associated epitope of variant hnrnpg and uses thereof |
| 04/30/2009 | CA2703126A1 Transformation and regeneration allium plants |
| 04/30/2009 | CA2702924A1 Novel atp:citrate lyase genes |
| 04/30/2009 | CA2702637A1 Fully human anti-vegf antibodies and methods of using |
| 04/30/2009 | CA2702333A1 Anti-ricin antibody |
| 04/30/2009 | CA2701802A1 Compositions for detecting antibodies to babesia microti and methods of use thereof |
| 04/30/2009 | CA2700522A1 Novel hiv targets |
| 04/30/2009 | CA2660123A1 Nuclear reprogramming method |
| 04/30/2009 | CA2607915A1 New cell models |
| 04/29/2009 | EP2053409A1 Specific markers for metabolic syndrome |
| 04/29/2009 | EP2053408A2 A procedure for structural characterization of a recombinant polyclonal protein or a polyclonal cell line |
| 04/29/2009 | EP2053402A1 Fluorescent marker for living organism and fluorescent marking method for the same |
| 04/29/2009 | EP2053398A1 Method for confirming performance of optical detector and reference reagent used for same |
| 04/29/2009 | EP2053135A1 Bone morphonic proteins (BMP), BMP receptors and BMP binding proteins and their use in the diagnosis and treatment of glaucoma |
| 04/29/2009 | EP2053134A2 Detectably labeled dual conformation oligonucleotide probes, assays and kits |
| 04/29/2009 | EP2053130A1 Method for screening for vitamin d receptor ligand |
| 04/29/2009 | EP2053129A2 Method of diagnosing, monitoring, staging, imaging and treating various cancers |
| 04/29/2009 | EP2053128A1 Novel method for utilization of microbial mutant |
| 04/29/2009 | EP2053127A2 Isolated polynucleotides having a reduced or an increased content of epigenetic control motifs and uses thereof |
| 04/29/2009 | EP2053126A1 Streptococcus pneumoniae proteins and nucleic acid molecules |
| 04/29/2009 | EP2053125A1 Streptococcus pyogenes antigens |